skip to content

Department of Pharmacology

 
Author(s): 
Hills, RA, Tan, TK, Cohen, AA, Keeffe, JR, Keeble, AH, Gnanapragasam, PNP, Storm, KN, Hill, ML, Liu, S, Gilbert-Jaramillo, J, Afzal, M, Napier, A, James, WS, Bjorkman, PJ, Townsend, AR, Howarth, M
Abstract: 

UNLABELLED: Defending against future pandemics may require vaccine platforms that protect across a range of related pathogens. The presentation of multiple receptor-binding domains (RBDs) from evolutionarily-related viruses on a nanoparticle scaffold elicits a strong antibody response to conserved regions. Here we produce quartets of tandemly-linked RBDs from SARS-like betacoronaviruses coupled to the mi3 nanocage through a SpyTag/SpyCatcher spontaneous reaction. These Quartet Nanocages induce a high level of neutralizing antibodies against several different coronaviruses, including against viruses not represented on the vaccine. In animals primed with SARS-CoV-2 Spike, boost immunizations with Quartet Nanocages increased the strength and breadth of an otherwise narrow immune response. Quartet Nanocages are a strategy with potential to confer heterotypic protection against emergent zoonotic coronavirus pathogens and facilitate proactive pandemic protection. ONE SENTENCE SUMMARY: A vaccine candidate with polyprotein antigens displayed on nanocages induces neutralizing antibodies to multiple SARS-like coronaviruses.

Publication ID: 
1470723
Published date: 
24 February 2023
Publication source: 
pubmed
Publication type: 
Journal articles
Journal name: 
bioRxiv
Publication volume: 
Publisher: 
Parent title: 
Edition: 
Publication number: